User profiles for Mónica Vázquez-Del Mercado
 | Dra. Monica Vazquez-del MercadoUniversidad de Guadalajara Verified email at academicos.udg.mx Cited by 3209 |
IL‐17 increased in the third trimester in healthy women with term labor
…, M Vázquez‐Del Mercado - American journal of …, 2011 - Wiley Online Library
… MH, Zuñiga‐Tamayo D, Vargas‐Ramírez R, Vázquez‐Del Mercado M. IL‐17 Increased
in the third trimester in healthy women with term labor. Am J Reprod Immunol 2011; 65: 99–103 …
in the third trimester in healthy women with term labor. Am J Reprod Immunol 2011; 65: 99–103 …
[HTML][HTML] Implications in the difference of anti-Mi-2 and-p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara
…, SJ Ross, EKL Chan, M Vázquez-Del Mercado - Arthritis research & …, 2013 - Springer
Introduction Autoantibodies and clinical manifestations in polymyositis/dermatomyositis (PM/DM)
are affected by both genetic and environmental factors. The high prevalence of DM and …
are affected by both genetic and environmental factors. The high prevalence of DM and …
[HTML][HTML] Anti-cyclic citrullinated peptide antibodies and severity of interstitial lung disease in women with rheumatoid arthritis
…, M Vázquez-del Mercado… - Journal of immunology …, 2015 - hindawi.com
Objective. To evaluate whether serum titers of second-generation anticyclic citrullinated
peptide antibodies (anti-CCP2) are associated with the severity and extent of interstitial lung …
peptide antibodies (anti-CCP2) are associated with the severity and extent of interstitial lung …
Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases
M Satoh, M Vázquez-Del Mercado… - Modern …, 2009 - academic.oup.com
Autoantibody tests have been used extensively in diagnosis and follow-up of patients in
rheumatology clinics. Immunofluorescent antinuclear antibody test using HEp-2 cells is still …
rheumatology clinics. Immunofluorescent antinuclear antibody test using HEp-2 cells is still …
Actualización de la Guía mexicana para el tratamiento farmacológico de la artritis reumatoide del Colegio Mexicano de Reumatología
…, A Díaz-Borjón, MV del Mercado Espinosa… - Reumatología …, 2014 - Elsevier
Antecedentes El manejo de la artritis reumatoide ha tenido avances muy importantes en los
últimos años. Las guías de práctica clínica requieren una actualización constante. …
últimos años. Las guías de práctica clínica requieren una actualización constante. …
Expression of ICAM1 and VCAM1 serum levels in rheumatoid arthritis clinical activity. Association with genetic polymorphisms
…, E Oregon-Romero, MVD Mercado… - Disease …, 2009 - content.iospress.com
To investigate the association of sICAM-1 and sVCAM-1 with ICAM1 721G> A and VCAM1
1238G> C polymorphisms and rheumatoid arthritis (RA) clinical activity, sixty RA patients and …
1238G> C polymorphisms and rheumatoid arthritis (RA) clinical activity, sixty RA patients and …
The EuroMyositis registry: an international collaborative tool to facilitate myositis research
…, NTP Thuy, M Vazquez-Del Mercado… - Annals of the …, 2018 - ard.bmj.com
Aims The EuroMyositis Registry facilitates collaboration across the idiopathic inflammatory
myopathy (IIM) research community. This inaugural report examines pooled Registry data. …
myopathy (IIM) research community. This inaugural report examines pooled Registry data. …
The+ 49A> G CTLA-4 polymorphism is associated with rheumatoid arthritis in Mexican population
…, I Parra-Rojas, H Rangel-Villalobos, MV del Mercado… - Clinica chimica acta, 2010 - Elsevier
BACKGROUND: The Cytotoxic T lymphocyte antigen (CTLA-4) is one of the major susceptibility
genes associated with autoimmune diseases. Susceptibility to rheumatoid arthritis (RA) …
genes associated with autoimmune diseases. Susceptibility to rheumatoid arthritis (RA) …
[HTML][HTML] The Montreal cognitive assessment test: a useful tool in screening of cognitive impairment in patients with systemic lupus erythematosus
…, M Vázquez-Del Mercado - JCR: Journal of …, 2019 - journals.lww.com
Methods This observational cross-sectional study recruited 44 patients, from August to
December 2017, who were diagnosed with SLE according to the Systemic Lupus International …
December 2017, who were diagnosed with SLE according to the Systemic Lupus International …
Efficacy of methotrexate in ankylosing spondylitis: a randomized, double blind, placebo controlled trial.
…, A Garcia-Gonzalez, M Vazquez-Del-Mercado… - The Journal of …, 2004 - jrheum.org
OBJECTIVE: To evaluate the efficacy and safety of methotrexate (MTX) compared with placebo
in patients with active ankylosing spondylitis (AS). METHODS: This 24 week, double bind…
in patients with active ankylosing spondylitis (AS). METHODS: This 24 week, double bind…